Rockin' HIT Sales Podcast
AI Governance in the Real World: What Vendors Need Before Provider Review
Dr. Yasir Tarabichi, Chief Health AI Officer at MetroHealth, joins Rockin’ HIT Sales to explain how health systems think about AI governance, provider review, risk, monitoring, and what vendors need to prepare before bringing AI-enabled tools into the organization.
Watch or Listen
Choose your preferred platform:
Also available on all major podcast platforms.
Episode Summary
AI governance has quickly moved from a niche technology discussion to a core part of how health systems evaluate new solutions. But what actually happens inside a provider organization when an AI-enabled product is introduced for review?
In this episode of Rockin' HIT Sales, Dr. Yasir Tarabichi shares a real world look at how health systems think about AI governance, risk, implementation, monitoring, and responsible adoption. Along the way, he explains why some vendors build trust early while others create friction before formal review even begins.
For Health IT founders, product leaders, GTM teams, and investors, this conversation offers a valuable glimpse into the questions provider organizations are asking—and what companies should be prepared to address long before an AI solution reaches a governance committee.
Why This Matters for Health IT Companies
AI-enabled Health IT solutions are not evaluated on performance alone. Health systems increasingly want to understand how a solution fits their strategy and workflow, what risks it introduces, how those risks will be monitored and mitigated, and whether the vendor can support responsible implementation over time.
For AI companies, governance readiness therefore needs to begin before formal provider review. Vendors that can explain the problem they solve, the implementation lift, population-specific validation, monitoring plans, risk mitigation, and how they will work with the health system after deployment are in a much stronger position to build trust than companies that lead primarily with the sophistication of the model.What You’ll Hear in This Episode
- What AI governance actually means inside the walls of a health system
- How an AI-enabled product, internal idea, or vendor solution enters the provider review process
- What mature vendors do differently that helps them develop trust
- When AI readiness should be addressed in the sales process — especially when early discussion may be with staff who are not deeply technical
- What companies should be prepared to explain before formal AI governance review begins
- What is one thing AI companies should just stop saying or doing when talking to a health system? (His answer will surprise you.)
Questions This Episode Answers
What does AI governance actually mean inside a health system?
AI governance is more than a committee or approval step. It is a way of working that establishes organizational expectations, accountability, transparency, responsibilities, risk thresholds, and how AI solutions will be selected, implemented, and monitored.
How does an AI-enabled solution enter a health system’s review process?
The path depends on the solution’s strategic importance, cost, implementation requirements, and risk. Enterprise-wide or higher-risk solutions typically receive greater executive and governance scrutiny, while lower-risk tools that fit existing priorities and technology may have a more streamlined path.
What makes an AI vendor appear mature to a health system?
Mature vendors can clearly explain the problem they solve, the implementation effort required, how performance will be measured in the provider’s environment, how risk will be identified, and what happens if performance changes after deployment.
When should AI governance readiness enter the sales conversation?
As early as possible. Even when an initial buyer is a clinical or operational leader rather than an AI expert, vendors should be prepared to explain how the solution performs for that provider’s population and workflow, how it will be monitored, and how governance and risk have been considered.
What should AI vendors stop doing when selling to health systems?
Leading with the fact that the product uses AI. The technology itself is not the value proposition. Providers are more interested in the problem being solved and whether the solution can be responsibly implemented, monitored, and governed.
When is an AI company truly ready for provider review?
When it can explain how the solution will be implemented, monitored, and governed—not simply how well the model performs.
David’s GTM Takeaways for AI-Enabled Health IT Vendors
Dr. Tarabichi’s comments on AI governance and vendor readiness connect directly to this white paper on what health systems will ask before approving AI-enabled Health IT solutions. Included is a self-assessment workbook.
White Paper: What Health Systems Will Ask Your AI
About the Guest
Dr. Yasir Tarabichi, MD, MSCR, FAMIA, is Head of Digital and Chief Medical Informatics Officer at Ovatient, a MetroHealth venture, and Chief Health AI Officer at MetroHealth. His work spans digital transformation, clinical informatics, virtual care, interoperability, and responsible AI governance.
At MetroHealth, Dr. Tarabichi leads enterprise AI strategy, governance, and implementation across the AI lifecycle, with a focus on responsible deployment, monitoring, and real-world clinical impact. His work includes the design, validation, and implementation of EHR-based predictive models and advanced clinical decision support, with particular attention to how AI can be safely and responsibly adopted in a community health system environment.Transcript
Prefer to read or download the conversation?